1. Home
  2. HAWK vs NKTR Comparison

HAWK vs NKTR Comparison

Compare HAWK & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HawkEye 360 Inc. Common Stock

HAWK

HawkEye 360 Inc. Common Stock

N/A

Current Price

$16.34

Market Cap

2.0B

Sector

Technology

ML Signal

N/A

Logo Nektar Therapeutics

NKTR

Nektar Therapeutics

HOLD

Current Price

$69.12

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HAWK
NKTR
Founded
N/A
1990
Country
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.2B
IPO Year
2026
1996

Fundamental Metrics

Financial Performance
Metric
HAWK
NKTR
Price
$16.34
$69.12
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$146.67
AVG Volume (30 Days)
1.1M
509.5K
Earning Date
N/A
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$307,711,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
86.00
52 Week Low
$16.24
$33.40
52 Week High
$25.71
$109.00

Technical Indicators

Market Signals
Indicator
HAWK
NKTR
Relative Strength Index (RSI) 29.43 44.65
Support Level N/A $70.24
Resistance Level $20.83 $76.49
Average True Range (ATR) 1.15 2.88
MACD -0.47 -0.31
Stochastic Oscillator 6.08 15.34

Price Performance

Historical Comparison
HAWK
NKTR

About HAWK HawkEye 360 Inc. Common Stock

Hawkeye 360 Inc operates in the signals intelligence (SIGINT) and defense technology sector. It provides end-to-end signals intelligence solutions integrated into national security systems for the United States and allied customers. Its offerings include radio frequency data and related insights to support defense operations. The company is involved across the value chain, including satellite design and manufacturing, data collection, and data processing and analysis. It generates revenue prominently from fixed price contract arrangements for RF signal mapping products that are used to analyze and track radio waves.

About NKTR Nektar Therapeutics

Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.

Share on Social Networks: